Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.
Latest News
3Shape's TRIOS MOVE Pro Scanner Cart Wins Red Dot 2026 Design Award
AI Usage Among 7th Gen Galaxy Foldables Users Grows in Southeast Asia and Oceania as Mobile Continues to be the Primary Gateway to AI
Take Five: A crude summer
Bank of England to keep rate steady despite oil and gas price rebound
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Website | https://www.reckitt.com |
| Audit Risk | 4 |
| Board Risk | 2 |
| Overall Risk | 1 |
| Market Cap | 31.84B |
| Trailing P/E | 10.25 |
| Forward P/E | 13.89 |
| Dividend Rate | 2.16 |
| Dividend Yield | 4.36% |
| Trailing Annual Div. Rate | 2.12 |
| Trailing Annual Div. Yield | 0.04% |
| Trailing EPS | 4.89 |
| Forward EPS | 3.61 |
| Book Value | 12 |
| Price-to-Book | 417.83 |
| Enterprise-to-Revenue | 2.72 |
| Enterprise-to-EBITDA | 10.24 |
| Ex-Dividend Date | 04/09/2026 |
| Earnings Date | |
| Earnings Call Date | 07/29/2026 |
| Revenue Average | 3.19B |
| Revenue Low | 3.17B |
| Revenue High | 3.21B |